Literature DB >> 18793303

Testicular lesions other than germ cell tumours: feasibility of testis-sparing surgery.

Corey Passman1, Donald Urban, Katrin Klemm, Mark Lockhart, Phillip Kenney, Peter Kolettis.   

Abstract

OBJECTIVE: To review all non-germ-cell testicular lesions presenting at our institution and to determine the feasibility of testis-sparing surgery for these patients. PATIENTS AND METHODS: All surgery for testicular masses between June 1995 and June 2005 were reviewed retrospectively. Patients with atrophy, germ cell tumours, infection or torsion were excluded. The study comprised men who had radical orchidectomy for suspected germ-cell tumour but had other final pathology, and those where testis-sparing surgery was attempted for a presumed benign lesion.
RESULTS: Thirteen patients with lesions appropriate for the study were identified; all but one had a palpable lesion. The lesions could be categorized as inflammatory (three hyalinized fibrosis, two sarcoidosis, one chronic inflammation), cystic (one epidermoid cyst, one unilocular cyst), benign neoplasms (two adenomatoid tumours, one Leydig cell tumour, one capillary haemangioma) or malignant neoplasms (one lymphoma). Based on the preoperative impression, testis-sparing surgery was attempted in eight of the lesions and was successful in six where it was attempted. In the other five, testis-sparing surgery was not attempted because the preoperative impression was that of a germ cell tumour. Testis-sparing surgery was successful in only six of the 13 patients with these lesions.
CONCLUSION: Testis-sparing surgery might be possible if there is significant suspicion of a benign lesion. If frozen-section analysis is equivocal, a radical orchidectomy is required. Testis-sparing surgery was feasible in highly selected cases.

Entities:  

Mesh:

Year:  2008        PMID: 18793303     DOI: 10.1111/j.1464-410X.2008.07986.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

1.  Systemic sarcoidosis mimicking advanced testicular cancer.

Authors:  Richard Woolf; Laurence Toms; Bobby Mann
Journal:  J R Soc Med       Date:  2010-06       Impact factor: 5.344

Review 2.  [Testicular tumors in prepubertal boys-organ preservation possible more often than expected].

Authors:  R Stein; M Dürken; K Zahn; Nina Younsi
Journal:  Urologe A       Date:  2020-03       Impact factor: 0.639

Review 3.  Organ-sparing approaches for testicular masses.

Authors:  Alvaro Zuniga; Nathan Lawrentschuk; Michael A S Jewett
Journal:  Nat Rev Urol       Date:  2010-08       Impact factor: 14.432

Review 4.  Contemporary diagnostic work-up of testicular germ cell tumours.

Authors:  Klaus-Peter Dieckmann; Ulrich Frey; Guntram Lock
Journal:  Nat Rev Urol       Date:  2013-11-12       Impact factor: 14.432

5.  Testis sparing surgery in a case of small unilateral testicular cancer.

Authors:  Hakkı Uzun; Sabri Oğullar; İbrahim Şehitoğlu; Görkem Akça; Orhan Ünal Zorba
Journal:  Turk J Urol       Date:  2013-12

6.  Multiparametric sonographic imaging of a capillary hemangioma of the testis: appearances on gray-scale, color Doppler, contrast-enhanced ultrasound and strain elastography.

Authors:  Silvia Bernardo; Eleni Konstantatou; Dean Y Huang; Annamaria Deganello; Marianna Philippidou; Christian Brown; Maria E Sellars; Paul S Sidhu
Journal:  J Ultrasound       Date:  2015-11-27

7.  Leydig cell tumors of the testis: a case report.

Authors:  Ancuta Augustina Gheorghisan-Galateanu
Journal:  BMC Res Notes       Date:  2014-09-18

8.  Capillary hemangioma of the testis. A case report of a rare benign tumor.

Authors:  Waldemar Białek; Sławomir Rudzki; Lech Wronecki
Journal:  J Ultrason       Date:  2016-03-29

9.  Testicular sarcoidosis masquerading as testicular carcinoma.

Authors:  James Joel; Jennifer Thomas; Kanwar Gill; Chandra Shekhar Biyani
Journal:  Cent European J Urol       Date:  2014-08-18

10.  Testicular hemangioma mimicking a malignant neoplasm.

Authors:  Rafik Ben Abda; Daniel Bess; Neris Nieves-Robbins
Journal:  Radiol Case Rep       Date:  2016-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.